Mardi, 16 Octobre 2018
Dernières nouvelles
Principale » Sanders Morris Harris LLC Holds Stake in Astrazeneca PLC (NYSE:AZN)

Sanders Morris Harris LLC Holds Stake in Astrazeneca PLC (NYSE:AZN)

09 Août 2017

Deutsche Bank AG reaffirmed a sell rating and set a GBX 160 ($2.08) price objective on shares of Centrica PLC in a research note on Sunday, July 9th.

AZN has been the topic of several research analyst reports.

The company has just set a TP of GBX 5500.00 on AstraZeneca PLC (LON:AZN) shares. (The) reissued a "sell" rating on shares of Astrazeneca PLC in a report on Thursday, July 13th. The stock of Pembina Pipeline Corp (NYSE:PBA) has "Neutral" rating given on Monday, June 20 by Credit Suisse. AstraZeneca plc has a consensus rating of Hold and an average target price of GBX 4,937.43 ($64.30). The company now has a consensus rating of "Hold" and an average price target of GBX 4,937.43 ($64.30).

Astrazeneca PLC (AZN) traded up 0.0675% during midday trading on Tuesday, hitting $30.0803. About shares traded. NuStar Energy L.P. (NYSE:NS) has declined 5.14% since August 7, 2016 and is downtrending. Centrica PLC has a 1-year low of GBX 119.71 and a 1-year high of GBX 248.39. The company has market cap of $74.54 billion. The company has a 50 day moving average of GBX 5,034.88 and a 200-day moving average of GBX 4,860.77. The company reported $0.87 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.41 by $0.46. The company had revenue of $5.05 billion during the quarter, compared to the consensus estimate of $5.04 billion. The company's revenue for the quarter was down 9.9% compared to the same quarter a year ago. In a note sent to investors on Monday, 7 August, Barclays Capital restate their "Overweight" rating on shares of AZN.

CSX Corporation (CSX): Ignore the noise and focus on the technicals
Following the completion of the acquisition, the director now directly owns 106 shares in the company, valued at $5,468.54. Shares buyback plans are usually an indication that the company's board of directors believes its shares are undervalued.

TRADEMARK VIOLATION NOTICE: "Astrazeneca PLC (AZN) to Issue None Dividend of $0.44 on September 11th" was first published by Rincon Hill News and is the property of of Rincon Hill News. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of United States and worldwide copyright legislation. The original version of this piece can be viewed at https://www.baseball-news-blog.com/2017/08/08/astrazeneca-plc-nyseazn-position-held-by-sanders-morris-harris-llc-updated-updated-updated.html.

The business also recently announced a None dividend, which will be paid on Monday, September 11th. The firm has "Buy" rating given on Thursday, August 6 by Investec. The indicated annual dividend is $1.81. Astrazeneca PLC's dividend payout ratio is presently 44.92%. Puzo Michael J sold 11,625 shares as Pembina Pipeline Co (PBA)'s stock declined 0.40%. Hayek Kallen Investment Management acquired a new position in shares of Astrazeneca PLC during the second quarter worth approximately $211,000.

In other news, insider Nazneen Rahman bought 39 shares of AstraZeneca plc stock in a transaction on Thursday, July 27th. The Corda Investment Management Llc holds 222,868 shares with $23.16 million value, up from 170,514 last quarter. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and eight have issued a buy rating to the company. The shares were bought at an average cost of GBX 4,370 ($56.91) per share, for a total transaction of £1,704.30 ($2,219.43).

Stockman Asset Management increased Astrazeneca Plc (AZN) stake by 24% reported in 2016Q4 SEC filing.

Sanders Morris Harris LLC Holds Stake in Astrazeneca PLC (NYSE:AZN)